Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease

Area of Science:

• Neuroscience
• Pathology
• Neurology

Background:

• Pathological tau accumulation in the brain is a hallmark of tauopathies, including Alzheimer's disease.
• In healthy neurons, tau is axonal, but it mislocalizes to soma and dendrites in disease states.
• Soluble tau species are implicated in early-stage synaptic and neuronal dysfunction preceding cell death.

Purpose of the Study:

• To review the current understanding of tau-mediated synaptic and neuronal dysfunction in cognitive decline.
• To explore the mechanisms by which pathogenic tau impacts synapses, dendrites, and axons.
• To provide a foundation for developing novel therapeutic strategies for tauopathies.

Main Methods:

• Literature review of current research on tau pathology and its effects on neuronal function.
• Analysis of studies investigating the role of soluble tau in early disease stages.
• Synthesis of findings on tau's impact on synaptic, dendritic, and axonal compartments.

Main Results:

• Pathological tau accumulates in various neuronal compartments, including presynaptic and postsynaptic sites.
• Soluble tau initiates brain pathophysiology by altering synaptic and neuronal functions early in disease progression.
• Tau-mediated dysfunction of synapses, dendrites, and axons contributes significantly to cognitive impairments.

Conclusions:

• Understanding the mechanisms of tau-induced neuronal dysfunction is crucial for treating tauopathies.
• Targeting tau's effects on synaptic and neuronal function may offer new therapeutic avenues.
• Further research into how pathogenic tau alters neuronal structures can guide the development of restorative strategies.